Srdjan Novaković

3.5k total citations
114 papers, 1.3k citations indexed

About

Srdjan Novaković is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Srdjan Novaković has authored 114 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 29 papers in Oncology and 29 papers in Genetics. Recurrent topics in Srdjan Novaković's work include BRCA gene mutations in cancer (22 papers), Lymphoma Diagnosis and Treatment (13 papers) and Immunotherapy and Immune Responses (12 papers). Srdjan Novaković is often cited by papers focused on BRCA gene mutations in cancer (22 papers), Lymphoma Diagnosis and Treatment (13 papers) and Immunotherapy and Immune Responses (12 papers). Srdjan Novaković collaborates with scholars based in Slovenia, United States and Czechia. Srdjan Novaković's co-authors include Vida Stegel, Janez Žgajnar, Gregor Serša, Barbara Jezeršek Novaković, Irma Virant‐Klun, Marko Hočevar, Damijan Miklavčič, Mateja Krajc, Eda Vrtačnik Bokal and Branko Cvjetičanin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Srdjan Novaković

107 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Srdjan Novaković Slovenia 22 557 292 230 202 183 114 1.3k
Alison M. Karst United States 18 927 1.7× 578 2.0× 137 0.6× 215 1.1× 132 0.7× 21 1.8k
Boris Minev United States 26 824 1.5× 517 1.8× 238 1.0× 41 0.2× 73 0.4× 61 2.1k
Ingrid B.J. Joseph United States 17 565 1.0× 315 1.1× 137 0.6× 56 0.3× 38 0.2× 40 1.2k
Abdeljabar El Andaloussi United States 19 540 1.0× 494 1.7× 83 0.4× 174 0.9× 71 0.4× 36 1.7k
Agnes S. Lo United States 20 418 0.8× 505 1.7× 140 0.6× 56 0.3× 80 0.4× 28 1.4k
Alfredo A. Molinolo United States 20 672 1.2× 562 1.9× 213 0.9× 24 0.1× 128 0.7× 30 1.6k
Michela Pasello Italy 24 869 1.6× 475 1.6× 95 0.4× 127 0.6× 112 0.6× 45 1.8k
Daniel Wu United States 21 1.1k 1.9× 767 2.6× 114 0.5× 70 0.3× 756 4.1× 37 2.3k
Mercedes Gallardo Spain 13 1.1k 1.9× 500 1.7× 253 1.1× 30 0.1× 95 0.5× 14 1.7k
Jian Yu China 20 1.1k 2.0× 584 2.0× 78 0.3× 45 0.2× 214 1.2× 69 1.8k

Countries citing papers authored by Srdjan Novaković

Since Specialization
Citations

This map shows the geographic impact of Srdjan Novaković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srdjan Novaković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srdjan Novaković more than expected).

Fields of papers citing papers by Srdjan Novaković

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srdjan Novaković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srdjan Novaković. The network helps show where Srdjan Novaković may publish in the future.

Co-authorship network of co-authors of Srdjan Novaković

This figure shows the co-authorship network connecting the top 25 collaborators of Srdjan Novaković. A scholar is included among the top collaborators of Srdjan Novaković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srdjan Novaković. Srdjan Novaković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miljković, Milica, et al.. (2025). Are there clinically relevant prognostic factors in diffuse large B-cell lymphoma beyond International Prognostic Index?. Radiology and Oncology. 59(4). 607–616.
2.
Gašljević, Gorana, et al.. (2023). CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological, and molecular characteristics with literature review. Radiology and Oncology. 57(2). 249–256. 1 indexed citations
3.
Ribnikar, Domen, Ivica Ratoša, Zachary Veitch, et al.. (2023). Association between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapy. Radiology and Oncology. 57(2). 220–228. 1 indexed citations
4.
Mencinger, Marina, Veronika Kloboves Prevodnik, Srdjan Novaković, & Boštjan Šeruga. (2023). 2337P Feasibility of mutation detection in cytological samples from metastasis in patients with metastatic prostate cancer. Annals of Oncology. 34. S1192–S1192.
5.
Novaković, Srdjan, et al.. (2023). Correlation of t(14;18) translocation breakpoint site with clinical characteristics in follicular lymphoma. Radiology and Oncology. 57(4). 487–492. 1 indexed citations
6.
Novaković, Srdjan, Vida Stegel, Barbara Gazić, et al.. (2020). The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients – Slovenian population based study. Radiology and Oncology. 54(2). 180–186. 3 indexed citations
7.
Hošnjak, Lea, Vida Stegel, Srdjan Novaković, et al.. (2020). Risk factors for the development of high‐grade dysplasia and carcinoma in patients with laryngeal squamous cell papillomas: Large retrospective cohort study. Head & Neck. 43(3). 956–966. 7 indexed citations
8.
Novaković, Srdjan, et al.. (2018). Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma. Radiology and Oncology. 52(3). 289–295. 9 indexed citations
9.
Ivanuš, Urška, Iztok Takač, Veronika Kloboves Prevodnik, et al.. (2018). Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches. Radiology and Oncology. 52(4). 399–412. 25 indexed citations
10.
Perme, Maja Pohar, et al.. (2017). The effect of CD34 + cell telomere length and hTERT expression on the outcome of autologous CD34 + cell transplantation in patients with chronic heart failure. Mechanisms of Ageing and Development. 166. 42–47. 4 indexed citations
11.
Perme, Maja Pohar, et al.. (2015). Functional variants in CYP1B1, KRAS and MTHFR genes are associated with shorter telomere length in postmenopausal women. Mechanisms of Ageing and Development. 149. 1–7. 2 indexed citations
12.
Novaković, Barbara Jezeršek, et al.. (2013). Clonality analysis of lymphoid proliferations using the BIOMED-2 clonality assays: a single institution experience. Radiology and Oncology. 48(2). 155–162. 17 indexed citations
13.
14.
Perić, Barbara, et al.. (2011). Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma. BMC Cancer. 11(1). 328–328. 32 indexed citations
15.
Bešič, Nikola, Jacques De Grève, Mateja Krajc, et al.. (2008). BRCA2 Gene Mutations in Slovenian Male Breast Cancer Patients. Genetic Testing. 12(2). 203–209. 15 indexed citations
16.
Virant‐Klun, Irma, Primož Rožman, Branko Cvjetičanin, et al.. (2008). Parthenogenetic Embryo-Like Structures in the Human Ovarian Surface Epithelium Cell Culture in Postmenopausal Women with No Naturally Present Follicles and Oocytes. Stem Cells and Development. 18(1). 137–150. 115 indexed citations
17.
Kopitar, Andreja Nataša, Vida Stegel, Bojan Tepeš, et al.. (2006). Specific T cell responses to Helicobacter pylori predict successful eradication therapy. Journal of Infection. 54(3). 257–261. 13 indexed citations
18.
Novaković, Srdjan & Vida Stegel. (2005). Rapid detection of most frequent Slovenian germ-line mutations in BRCA1 gene using real-time PCR and melting curve analysis. Radiology and Oncology. 39(2). 2 indexed citations
19.
Novaković, Srdjan. (2004). Tumor markers in clinical oncology. Radiology and Oncology. 38(2). 10 indexed citations
20.
Menart, Viktor, et al.. (1996). Searching for new TNF-α analogs having potential application in cancer therapy. Pflügers Archiv - European Journal of Physiology. 431(S6). R233–R234. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alison M. Karst Breakdown of academic impact, for papers by Boris Minev Breakdown of academic impact, for papers by Ingrid B.J. Joseph Breakdown of academic impact, for papers by Abdeljabar El Andaloussi Breakdown of academic impact, for papers by Agnes S. Lo Breakdown of academic impact, for papers by Alfredo A. Molinolo Breakdown of academic impact, for papers by Michela Pasello Breakdown of academic impact, for papers by Daniel Wu Breakdown of academic impact, for papers by Mercedes Gallardo Breakdown of academic impact, for papers by Jian Yu
Rankless by CCL
2026